Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

0.6869
Delayed Data
As of Feb 12
 +0.0039 / +0.57%
Today’s Change
0.65
Today|||52-Week Range
3.72
-23.47%
Year-to-Date
No recent news for Sunesis Pharmaceuticals Inc.

Today’s Trading

Previous close0.68
Today’s open0.71
Day’s range0.66 - 0.72
Volume126,330
Average volume (3 months)345,994
Market cap$58.4M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-15.15%
Earnings growth (this year)+29.82%
Earnings growth (next 5 years)--
Revenue growth (last year)-27.93%
P/E ratioNM
Price/Sales27.35
Price/Book3.29

Competitors

 Today’s
change
Today’s
% change
REPHRecro Pharma Inc-0.33-5.00%
OCRXOcera Therapeutics I...+0.06+2.21%
EPRSEPIRUS Biopharmaceut...-0.21-8.30%
AXNAoxing Pharmaceutica...+0.05+6.76%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 9, 2016
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$5.7M
Annual profit (last year)-$43.0M
Net profit margin-749.95%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers